Literature DB >> 7952630

Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer.

L N Lee1, J Y Shew, J C Sheu, Y C Lee, W C Lee, M T Fang, H F Chang, C J Yu, P C Yang, K T Luh.   

Abstract

The epidemiologic characteristics of lung cancer in Taiwan differ from those in other parts of the world in low male-to-female ratio, the high percentage of adenocarcinoma, and the relatively high percentage of nonsmokers who are victims. To investigate possible correlation between p53 gene alteration and the unique characteristics of lung cancer here, p53 gene status of 36 patients with primary, resected non-small-cell lung cancer (NSCLC) was studied by directly sequencing the cDNA of the p53 gene, then acquiring clinical and pathologic data to correlate p53 gene status with clinical parameters and pathologic staging. Missense mutations were present in 42% (15 of 36) of patients with NSCLC, including 42% (10 of 24) with adenocarcinomas, and 45% (five of 11) with squamous cell carcinomas. The frequency of p53 mutation was 50% in smokers and 29% in nonsmokers (p = 0.355). The mutation occurred most frequently in exon 8 (56%), and G:C to A:T transitions in non-CpG or CpG sites were the most commonly observed base changes (56%). These findings differ from the high prevalence of G to T transversion found in previous reports. The frequency of metastasis in hilar and mediastinal lymph nodes was significantly higher in tumors with p53 mutations. The association with nodal stage was strong for mutations within exon 8, but it was less apparent for mutations in other exons probably because of the small number. This study suggests that p53 gene missense is common in NSCLC in Taiwan, but smoking is probably not the sole contributing factor. More interestingly, p53 gene mutations, especially those in exon 8, may be associated with regional nodal metastasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952630     DOI: 10.1164/ajrccm.150.6.7952630

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  5 in total

1.  Tobacco smoke: chemical carcinogenesis and genetic lesions.

Authors:  J L Cook
Journal:  Ochsner J       Date:  1999-07

2.  The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization.

Authors:  Fang-Yi Lo; Jer-Wei Chang; I-Shou Chang; Yann-Jang Chen; Han-Shui Hsu; Shiu-Feng Kathy Huang; Fang-Yu Tsai; Shih Sheng Jiang; Rajani Kanteti; Suvobroto Nandi; Ravi Salgia; Yi-Ching Wang
Journal:  BMC Cancer       Date:  2012-06-12       Impact factor: 4.430

Review 3.  Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker.

Authors:  J C Semenza; L H Weasel
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

4.  p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.

Authors:  T Liloglou; H Ross; W Prime; R J Donnelly; D A Spandidos; J R Gosney; J K Field
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.

Authors:  A Marchetti; S Pellegrini; G Sozzi; G Bertacca; P Gaeta; F Buttitta; V Carnicelli; P Griseri; A Chella; C A Angeletti; M Pierotti; G Bevilacqua
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.